REG I Expression Predicts Long-term Survival among Locally Advanced Thoracic Squamous Cell Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Followed by Esophagectomy

By Motoyama Satoru   Sugiyama Toshihiro   Ueno Yasuharu   Okamoto Hiroshi   Takasawa Shin   Nanjo Hiroshi   Watanabe Hitoshi   Maruyama Kiyotomi   Okuyama Manabu   Ogawa Jun-ichi  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1724-1731

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of Neoadjuvant Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma

By Lee Jae-lyun   Kim Sung-bae   Jung Hwoon-yong   Park Seung-il   Kim Dong-kwan   Kim Jong-hoon   Song Ho-young   Kim Woo-kun   Lee Jung-shin   Min Young-il  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

STMN-1 Gene: A Predictor of Survival in Stage IIA Esophageal Squamous Cell Carcinoma After Ivor-Lewis Esophagectomy?

By Akhtar Javed   Wang Zhou   Yu Che   Zhang Zhi   Bi Ming  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 315-321

Springer Publishing Company

Access to resources Recommend Favorite

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5‐fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO‐07 study

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 721-731

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy

By Okumura Hiroshi  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 329-334

Springer Publishing Company

Access to resources Recommend Favorite